UTI AMC Q2 FY23 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
See what UTI AMC management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what UTI AMC management said on order book — free account, 30 seconds.
Capex plans
Track UTI AMC — get its next earnings analysis in your feed
How does UTI AMC rank vs peers in Capital Markets?
Pro featureHow does UTI AMC rank in Capital Markets?
Compare UTI AMC against every Capital Markets company (Q2 FY23) on revenue, margins and earnings-call signals.
Continue your research
What UTI AMC's management said in earlier quarters
Others in Capital Markets this season
- Systematix Corporate Services (Q2 FY27)
Q2 FY27 total revenue from operations (consolidated): ₹57.81 Cr, up 0.50% YoY vs. Key investor presentation takeaways from Systematix Corporate Services Ltd's Q
- Indo Thai Securities (Q2 FY27)
Q2 FY27 revenue excluding fair value changes: ₹7.56 Cr, up 18.7% year-on-year (Page 13) . Key investor presentation takeaways from Indo Thai Securities Ltd's Q2
- Gretex Corporate (Q2 FY27)
H1 FY27 saw an 11.4% year-on-year revenue growth, indicating positive momentum. Key concall takeaways from Gretex Corporate Services Ltd's Q2 FY27 earnings…
- Nuvama Wealth (Q2 FY27)
Wealth and Private Wealth businesses have consistently compounded >20% growth over the last three years. Key concall takeaways from Nuvama Wealth Management…